Cargando…
A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab
A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 che...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926357/ https://www.ncbi.nlm.nih.gov/pubmed/31890556 http://dx.doi.org/10.1016/j.rmcr.2019.100979 |
_version_ | 1783482080065224704 |
---|---|
author | Ito, Keima Oguri, Tetsuya Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Tajiri, Tomoko Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Niimi, Akio |
author_facet | Ito, Keima Oguri, Tetsuya Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Tajiri, Tomoko Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Niimi, Akio |
author_sort | Ito, Keima |
collection | PubMed |
description | A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 chemotherapy courses were administered over 2 years. Currently, he is being followed with no recurrence at least 10 months after treatment. Thus, the case of a patient with advanced lung cancer who was previously unsuccessfully treated with nivolumab and then demonstrated a long-term clinical response to a re-challenge with nivolumab after cytotoxic chemotherapy and radiation therapy is presented. |
format | Online Article Text |
id | pubmed-6926357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69263572019-12-30 A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab Ito, Keima Oguri, Tetsuya Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Tajiri, Tomoko Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Niimi, Akio Respir Med Case Rep Case Report A 76-year-old man was admitted to our hospital with cough and dyspnea. He was diagnosed with advanced lung cancer. Nivolumab was given as second-line treatment, cytotoxic chemotherapy was given as third-line treatment, and nivolumab re-challenge was given as fourth-line treatment. Thereafter, 41 chemotherapy courses were administered over 2 years. Currently, he is being followed with no recurrence at least 10 months after treatment. Thus, the case of a patient with advanced lung cancer who was previously unsuccessfully treated with nivolumab and then demonstrated a long-term clinical response to a re-challenge with nivolumab after cytotoxic chemotherapy and radiation therapy is presented. Elsevier 2019-12-10 /pmc/articles/PMC6926357/ /pubmed/31890556 http://dx.doi.org/10.1016/j.rmcr.2019.100979 Text en © 2019 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Ito, Keima Oguri, Tetsuya Takeda, Norihisa Fukumitsu, Kensuke Fukuda, Satoshi Kanemitsu, Yoshihiro Tajiri, Tomoko Ohkubo, Hirotsugu Takemura, Masaya Maeno, Ken Ito, Yutaka Niimi, Akio A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title | A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title_full | A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title_fullStr | A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title_full_unstemmed | A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title_short | A case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
title_sort | case of non-small cell lung cancer with long-term response after re-challenge with nivolumab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6926357/ https://www.ncbi.nlm.nih.gov/pubmed/31890556 http://dx.doi.org/10.1016/j.rmcr.2019.100979 |
work_keys_str_mv | AT itokeima acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT oguritetsuya acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT takedanorihisa acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT fukumitsukensuke acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT fukudasatoshi acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT kanemitsuyoshihiro acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT tajiritomoko acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT ohkubohirotsugu acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT takemuramasaya acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT maenoken acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT itoyutaka acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT niimiakio acaseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT itokeima caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT oguritetsuya caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT takedanorihisa caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT fukumitsukensuke caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT fukudasatoshi caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT kanemitsuyoshihiro caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT tajiritomoko caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT ohkubohirotsugu caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT takemuramasaya caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT maenoken caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT itoyutaka caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab AT niimiakio caseofnonsmallcelllungcancerwithlongtermresponseafterrechallengewithnivolumab |